Evox Therapeutics Limited
Research and experimental development on biotechnology · Oxford
ActiveUnited KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
10076821- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-03-22
- Jurisdiction
- —
- Registered office
- 1MEDAWAR CENTRE 2ND FLOOR, EAST BUILDING, OXFORD, OXFORDSHIRE, OX4 4HG, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
2 matched grantsTotal Body Nuclear Imaging for the Development of NanotheranosticsActiveEPSRC · Research Grant · 2026-01-05 – 2031-01-05 · with 20 other participants£9,980,399whole project
Total Body Nuclear Imaging for the Development of NanotheranosticsActive
EPSRC · Research Grant · 2026-01-05 – 2031-01-05 · with 20 other participants
£9,980,399
whole project
King'S College LondonleadAstral SystemsAstrazeneca UK LimitedCentre for Process Innovation CPI (UK)Cyclife Aquila NuclearEVOX Therapeutics LtdGE HealthcareInnoMedica Holding AGInternational Iberian Nanotechnology LaboratoryJohnson & Johnson (United Kingdom)McMaster UniversityMediso Medical Imaging Systems LtdNanotechnology Industries AssociationNational Nuclear Laboratory (Nnl)National PET Imaging Platform (NPIP)Perceptive DiscoveryPerspective TherapeuticsPrecision X-ray IrradiationSiemens Healthcare (Germany)Stream Bio LtdVacV Biotherapeutics
Exosome therapy for rare paediatric disorder Argininosuccinic AciduriaLeadInnovate UK · Collaborative R&D · 2019-02-01 – 2021-03-31 · with 1 other participant£827,244awarded
Exosome therapy for rare paediatric disorder Argininosuccinic AciduriaLead
Innovate UK · Collaborative R&D · 2019-02-01 – 2021-03-31 · with 1 other participant
£827,244
awarded
Evox Therapeutics Limitedlead£827,244